{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Foreign Desk", "lead_paragraph": "Victim by victim, AIDS is steadily boring through the heart of this small town. It killed the mayor's daughter. It has killed a fifth of the 60 employees of the town's biggest businessman. It has claimed an estimated one in eight teachers, several health workers and 2 of 10 counselors who teach prostitutes about protected sex. One of the 13 municipal workers has died of AIDS. Another is about to. A third is H.I.V.-positive.", "headline": {"main": "A HOLLOWED GENERATION: Plunge in Life Expectancy; Hut by Hut, AIDS Steals Life in a Southern Africa Town", "kicker": "A Hollowed Generation | Plunge in Life Expectancy"}, "abstract": "Article A Hollowed Generation describes how AIDS is steadily boring through heart of one small town in Africa, stealing life and breeding desperation as it is doing across continent; Lavumisa, Swaziland, has lost parents, teachers and health workers who leave behind destitute orphans with few healthy kin to care for them; tiny town of 2,000 is template for demographic plunge in every corner of southern Africa as AIDS reduces life expectancy to levels of 1800's; average child born today will not live to 40; photos; map; charts; terrible ripples that unrestrained epidemic sends through small village described; schools collapse, crime rises, medical clinics are jammed and family assets are sold to fend off hunger because adults are dead, and their deaths have robbed survivors of their own aspirations (L)", "print_page": "1", "word_count": 4058, "_id": "4fd2a5648eb7c8105d88ca7f", "snippet": "What happens to a society when its fulcrum - its mothers and fathers, teachers, nurses, farm workers - die in their prime?", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/28/international/africa/28swazi.html", "multimedia": [{"url": "images/2004/11/26/international/01.02.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2004/11/26/international/01.02.75.jpg"}, "type": "image", "height": 75}, {"subtype": "tiny_thumb", "legacy": {"tinythumbwidth": 55, "tinythumbheight": 55, "hastinythumb": "Y"}, "type": "image", "width": 55, "height": 55}], "subsection_name": null, "keywords": [{"name": "glocations", "value": "SWAZILAND"}, {"name": "glocations", "value": "AFRICA"}, {"name": "glocations", "value": "LAVUMISA (SWAZILAND)"}, {"name": "subject", "value": "SOCIAL CONDITIONS AND TRENDS"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME"}, {"name": "subject", "value": "GEOGRAPHIC PROFILES"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}, {"name": "subject", "value": "ACQUIRED IMMUNE DEFICIENCY SYNDROME (AIDS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "ECONOMIC CONDITIONS AND TRENDS"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Michael", "rank": 1, "lastname": "WINES"}, {"organization": "", "role": "reported", "firstname": "Sharon", "rank": 2, "lastname": "LaFRANIERE"}], "original": "By MICHAEL WINES and SHARON LaFRANIERE"}, "document_type": "article", "pub_date": "2004-11-28T00:00:00Z", "section_name": "World; Health"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: Dr. Donna J. Harrison of the American Association of Pro-Life Obstetricians and Gynecologists argues for the suspension of RU-486 on the basis of its alleged dangers.", "headline": {"main": "Safety Concerns About Abortion Drug"}, "abstract": "Diane Tider letter argues that RU-486 has been used safely worldwide and is crucial component in women's health (Nov 19 Donna J Harrison Op-Ed article)", "print_page": "22", "word_count": 136, "_id": "4fd23f208eb7c8105d7d65f7", "snippet": "To the Editor:    Dr. Donna J. Harrison of the American Association of Pro-Life Obstetricians and Gynecologists argues for the suspension of RU-486 on the basis of its alleged dangers.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A06EEDD143EF937A15752C1A9629C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "TIDER, DIANE"}, {"name": "persons", "value": "HARRISON, DONNA J"}, {"name": "subject", "value": "MIFEPREX (RU-486) (DRUG)"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": null, "document_type": "article", "pub_date": "2004-11-24T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: Re ''Dangerous Medicine,'' by Dr. Donna J. Harrison (Op-Ed, Nov. 19):", "headline": {"main": "Safety Concerns About Abortion Drug"}, "abstract": "Sandra Mathews letter says RU-486 can be used safely with proper education of doctors and patients (Nov 19 Donna J Harrison Op-Ed article)", "print_page": "22", "word_count": 102, "_id": "4fd25a018eb7c8105d806961", "snippet": "To the Editor:     Re ''Dangerous Medicine,'' by Dr. Donna J. Harrison (Op-Ed, Nov. 19):", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=940CEFDD143EF937A15752C1A9629C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "HARRISON, DONNA J"}, {"name": "persons", "value": "MATHEWS, SANDRA"}, {"name": "subject", "value": "MIFEPREX (RU-486) (DRUG)"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "DOCTORS"}], "byline": null, "document_type": "article", "pub_date": "2004-11-24T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Dr. David J. Graham, the drug safety reviewer who denounced his employer, the Food and Drug Administration, before a Congressional panel last week, said yesterday that he feared being fired and had sought legal help from a group that protects whistle-blowers. ''My concern is retaliation from these people,'' Dr. Graham said in a telephone interview.", "headline": {"main": "F.D.A. Employee Seeks Help From Whistle-Blowers' Group"}, "abstract": "Dr David J Graham, drug safety reviewer for FDA who denounced agency before Congressional panel, says he fears being fired and has sought legal help from group that protects whistle-blowers; says he is concerned about 'retaliation from these people' (M)", "print_page": "21", "word_count": 668, "_id": "4fd249828eb7c8105d7e6f2f", "snippet": "Dr. David J. Graham, the drug safety reviewer who denounced the F.D.A.'s safety record before a Congressional panel last week, said that he feared being fired.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/24/politics/24drug.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "GRAHAM, DAVID"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "ACCIDENTS AND SAFETY"}, {"name": "subject", "value": "WHISTLE-BLOWERS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Denise", "rank": 1, "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2004-11-24T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: The issue is not whether RU-486 has caused complications and death, but whether it has caused more adverse outcomes than alternate forms of abortion.", "headline": {"main": "Safety Concerns About Abortion Drug"}, "abstract": "Dr Anthony White letter suggests that Donna Harrison does not object to drug RU-486 as much as she does to abortion (Nov 19 Op-Ed article)", "print_page": "22", "word_count": 110, "_id": "4fd25a688eb7c8105d806eb7", "snippet": "To the Editor:    The issue is not whether RU-486 has caused complications and death, but whether it has caused more adverse outcomes than alternate forms of abortion.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9407EEDD143EF937A15752C1A9629C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "HARRISON, DONNA J"}, {"name": "persons", "value": "WHITE, ANTHONY"}, {"name": "subject", "value": "MIFEPREX (RU-486) (DRUG)"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}], "byline": null, "document_type": "article", "pub_date": "2004-11-24T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Obstetric researchers have done much in recent years to increase the safety and success of pregnancies among all women of reproductive age, even those approaching the end of their ability to conceive. But in one important area -- a disorder called preeclampsia --no significant improvement has occurred, even though its incidence has risen by nearly a third in the last decade.", "headline": {"main": "For Mother and Child, a Lurking Danger", "kicker": "PERSONAL HEALTH"}, "abstract": "Jane E Brody Personal Health column discusses preeclampsia, which is second leading cause of maternal death in United States; disorder is increasingly prevalent and affects about 5 to 8 percent of pregnant women; reasons for increased blood pressure during pregnancy and risk factors discussed; ways to control preeclampsia include bedrest and high blood pressure treatment, but attempts at controlling disorder often fail and many babies are delivered prematurely to ensure health of baby and mother; photo (M)", "print_page": "9", "word_count": 1190, "_id": "4fd280938eb7c8105d84badd", "snippet": "Although there are no proven ways to prevent preeclampsia, or toxemia of pregnancy, certain conditions are known to increase a woman's chances of developing it.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/23/health/23brod.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "creative_works", "value": "PERSONAL HEALTH (TIMES COLUMN)"}, {"name": "subject", "value": "LIFE STYLES"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "PREMATURE BABIES"}, {"name": "subject", "value": "PREECLAMPSIA"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "BLOOD PRESSURE"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "article", "pub_date": "2004-11-23T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Condoleezza Rice, the national security adviser, shares at least one thing with millions of other American women: she had fibroids, benign tumors in the uterus that required treatment. Ms. Rice, the nominee for secretary of state, entered the hospital for an overnight stay last week to undergo a procedure -- uterine artery embolization -- that is rapidly becoming an alternative to major surgery for troublesome fibroids.", "headline": {"main": "Treating Troubling Fibroids Without Surgery"}, "abstract": "National Security Adviser Condoleezza Rice recently underwent uterine artery embolization, alternative treatment for fibroids that is less invasive than surgery; procedure, which involves blocking blood to fibroids with plastic beads, described; Dr Evan R Myers of Duke University, acknowledges that while procedure is safe there are many unknowns about long-term outcome and impact on fertility; other treatments for fibroids discussed; drawing (M)", "print_page": "8", "word_count": 1093, "_id": "4fd280238eb7c8105d84b282", "snippet": "Condoleezza Rice shares at least one thing with millions of other American women: she had fibroids, benign tumors in the uterus that required treatment.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/11/23/health/23fibr.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "RICE, CONDOLEEZZA"}, {"name": "persons", "value": "MYERS, EVAN R"}, {"name": "organizations", "value": "DUKE UNIVERSITY"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "FIBROIDS"}, {"name": "subject", "value": "POLITICS AND GOVERNMENT"}, {"name": "subject", "value": "CANCER"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "UTERINE ARTERY EMBOLIZATION"}, {"name": "subject", "value": "SURGERY AND SURGEONS"}, {"name": "subject", "value": "UTERUS"}], "byline": {"person": [{"firstname": "Lawrence", "middlename": "K.", "lastname": "ALTMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By LAWRENCE K. ALTMAN"}, "document_type": "article", "pub_date": "2004-11-23T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 7, "offset": 0, "time": 56}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}